NASDAQ: NEO

NeoGenomics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of NeoGenomics, Inc. (NASDAQ: NEO) between February 27, 2020 and April 26, 2022, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for NeoGenomics investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than February 6, 2023. 

If you purchased NeoGenomics securities during the Class Period and would like to join the action, please click “Join This Class Action.”

 

Class Period:February 27, 2020 through April 26, 2022

Deadline:

7 Days
If you purchased NeoGenomics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements regarding the Company’s:

  • statements it was a “one-stop-shop” for cancer testing because it did not offer the most technologically advanced NGS tests, which led to a significant decrease in revenue as current and prospective customers went elsewhere for their testing needs;
  • costs, which were not fixed because the Company needed to hire additional employees to process more complex customized testing demanded by customers utilizing the Company’s outdated portfolio of tests, leading to operational challenges, decrease lab efficiency, and increased testing turnaround times; and
  • thus, the Company violated federal healthcare laws and regulations related to fraud, waste, and abuse

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: NeoGenomics
Stock Symbol: NEO
Class Period: February 27, 2020 through April 26, 2022
Court: United States District Court Southern District of New York

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top